APO Research
Talk to an analyst

APO RESEARCH · REPORT

NGS Tumor Gene Analysis Software

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global NGS Tumor Gene Analysis Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

4 July 2026194 pages

Choose your research edition.

Industry ResearchNGS Tumor Gene Analysis Software Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal NGS Tumor Gene Analysis Software Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal NGS Tumor Gene Analysis Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal NGS Tumor Gene Analysis Software Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal NGS Tumor Gene Analysis Software Market Analysis and Forecast 2026-2032173 pages · $4,950 USD

Market perspective

The global NGS Tumor Gene Analysis Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for NGS Tumor Gene Analysis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for NGS Tumor Gene Analysis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for NGS Tumor Gene Analysis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for NGS Tumor Gene Analysis Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of NGS Tumor Gene Analysis Software include Roche, Illumina, Thermo Fisher Scientific, BGI Group, Novogene, Geneseeq, AmoyDx, Burning Rock Medicine and GTH.O, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global NGS Tumor Gene Analysis Software market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of NGS Tumor Gene Analysis Software and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents NGS Tumor Gene Analysis Software revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the NGS Tumor Gene Analysis Software market size, projected growth trends, production technologies, key applications, and end-use industries.

NGS Tumor Gene Analysis Software Segment by Company

Roche

Illumina

Thermo Fisher Scientific

BGI Group

Novogene

Geneseeq

AmoyDx

Burning Rock Medicine

GTH.O

Golden Helix, Inc

Diatech Pharmacogenetics

ViennaLab Diagnostics GmbH

3D Medicines

NGS Tumor Gene Analysis Software Segment by Type

Non-Small Cell Lung Cancer

Human 6 Gene Mutations

Human 12 Gene Mutations

Other

NGS Tumor Gene Analysis Software Segment by Application

Hospitals and Health Systems

Research Institute

Other

NGS Tumor Gene Analysis Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global NGS Tumor Gene Analysis Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of NGS Tumor Gene Analysis Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of NGS Tumor Gene Analysis Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of NGS Tumor Gene Analysis Software in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global NGS Tumor Gene Analysis Software industry.

Chapter 3: Detailed analysis of NGS Tumor Gene Analysis Software companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, NGS Tumor Gene Analysis Softwarerevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global NGS Tumor Gene Analysis Software Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Non-Small Cell Lung Cancer Table 3. Key Players of Human 6 Gene Mutations Table 4. Key Players of Human 12 Gene Mutations Table 3. Key Players of Other Table 4. Global NGS Tumor Gene Analysis Software Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Hospitals and Health Systems Table 6. Key Players of Research Institute Table 7. Key Players of Other Table 8. Global NGS Tumor Gene Analysis Software Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global NGS Tumor Gene Analysis Software Market Size by Region (2021-2026) & (US$ Million) Table 10. Global NGS Tumor Gene Analysis Software Market Share by Region (2021-2026) Table 11. Global NGS Tumor Gene Analysis Software Market Size by Region (2027-2032) & (US$ Million) Table 12. Global NGS Tumor Gene Analysis Software Market Share by Region (2027-2032) Table 13. NGS Tumor Gene Analysis Software Industry Trends Table 14. NGS Tumor Gene Analysis Software Industry Drivers Table 15. NGS Tumor Gene Analysis Software Industry Opportunities and Challenges Table 16. NGS Tumor Gene Analysis Software Industry Restraints Table 17. Global NGS Tumor Gene Analysis Software Revenue by Company (US$ Million) & (2021-2026) Table 18. Global NGS Tumor Gene Analysis Software Revenue Market Share by Company (2021-2026) Table 19. Global NGS Tumor Gene Analysis Software Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global NGS Tumor Gene Analysis Software Key Company Head Office and Area Served Table 21. Global NGS Tumor Gene Analysis Software Company, Product Type & Application Table 22. Global NGS Tumor Gene Analysis Software Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global NGS Tumor Gene Analysis Software by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global NGS Tumor Gene Analysis Software Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global NGS Tumor Gene Analysis Software Market Size by Type (2021-2026) & (US$ Million) Table 27. Global NGS Tumor Gene Analysis Software Market Size by Type (2027-2032) & (US$ Million) Table 28. Global NGS Tumor Gene Analysis Software Revenue Market Share by Type (2021-2026) Table 29. Global NGS Tumor Gene Analysis Software Revenue Market Share by Type (2027-2032) Table 30. Global NGS Tumor Gene Analysis Software Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global NGS Tumor Gene Analysis Software Market Size by Application (2021-2026) & (US$ Million) Table 32. Global NGS Tumor Gene Analysis Software Market Size by Application (2027-2032) & (US$ Million) Table 33. Global NGS Tumor Gene Analysis Software Revenue Market Share by Application (2021-2026) Table 34. Global NGS Tumor Gene Analysis Software Revenue Market Share by Application (2027-2032) Table 35. Roche Company Information Table 36. Roche Business Overview Table 37. Roche NGS Tumor Gene Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Roche NGS Tumor Gene Analysis Software Product Portfolio Table 39. Roche Recent Development Table 40. Illumina Company Information Table 41. Illumina Business Overview Table 42. Illumina NGS Tumor Gene Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Illumina NGS Tumor Gene Analysis Software Product Portfolio Table 44. Illumina Recent Development Table 45. Thermo Fisher Scientific Company Information Table 46. Thermo Fisher Scientific Business Overview Table 47. Thermo Fisher Scientific NGS Tumor Gene Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. Thermo Fisher Scientific NGS Tumor Gene Analysis Software Product Portfolio Table 49. Thermo Fisher Scientific Recent Development Table 50. BGI Group Company Information Table 51. BGI Group Business Overview Table 52. BGI Group NGS Tumor Gene Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. BGI Group NGS Tumor Gene Analysis Software Product Portfolio Table 54. BGI Group Recent Development Table 55. Novogene Company Information Table 56. Novogene Business Overview Table 57. Novogene NGS Tumor Gene Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Novogene NGS Tumor Gene Analysis Software Product Portfolio Table 59. Novogene Recent Development Table 60. Geneseeq Company Information Table 61. Geneseeq Business Overview Table 62. Geneseeq NGS Tumor Gene Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Geneseeq NGS Tumor Gene Analysis Software Product Portfolio Table 64. Geneseeq Recent Development Table 65. AmoyDx Company Information Table 66. AmoyDx Business Overview Table 67. AmoyDx NGS Tumor Gene Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. AmoyDx NGS Tumor Gene Analysis Software Product Portfolio Table 69. AmoyDx Recent Development Table 70. Burning Rock Medicine Company Information Table 71. Burning Rock Medicine Business Overview Table 72. Burning Rock Medicine NGS Tumor Gene Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Burning Rock Medicine NGS Tumor Gene Analysis Software Product Portfolio Table 74. Burning Rock Medicine Recent Development Table 75. GTH.O Company Information Table 76. GTH.O Business Overview Table 77. GTH.O NGS Tumor Gene Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. GTH.O NGS Tumor Gene Analysis Software Product Portfolio Table 79. GTH.O Recent Development Table 80. Golden Helix, Inc Company Information Table 81. Golden Helix, Inc Business Overview Table 82. Golden Helix, Inc NGS Tumor Gene Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Golden Helix, Inc NGS Tumor Gene Analysis Software Product Portfolio Table 84. Golden Helix, Inc Recent Development Table 85. Diatech Pharmacogenetics Company Information Table 86. Diatech Pharmacogenetics Business Overview Table 87. Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 88. Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Product Portfolio Table 89. Diatech Pharmacogenetics Recent Development Table 90. ViennaLab Diagnostics GmbH Company Information Table 91. ViennaLab Diagnostics GmbH Business Overview Table 92. ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 93. ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Product Portfolio Table 94. ViennaLab Diagnostics GmbH Recent Development Table 95. 3D Medicines Company Information Table 96. 3D Medicines Business Overview Table 97. 3D Medicines NGS Tumor Gene Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026) Table 98. 3D Medicines NGS Tumor Gene Analysis Software Product Portfolio Table 99. 3D Medicines Recent Development Table 100. North America NGS Tumor Gene Analysis Software Market Size by Type (2021-2026) & (US$ Million) Table 101. North America NGS Tumor Gene Analysis Software Market Size by Type (2027-2032) & (US$ Million) Table 102. North America NGS Tumor Gene Analysis Software Market Size by Application (2021-2026) & (US$ Million) Table 103. North America NGS Tumor Gene Analysis Software Market Size by Application (2027-2032) & (US$ Million) Table 104. North America NGS Tumor Gene Analysis Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 105. North America NGS Tumor Gene Analysis Software Market Size by Country (2021-2026) Table 106. North America NGS Tumor Gene Analysis Software Market Size by Country (2027-2032) Table 107. Europe NGS Tumor Gene Analysis Software Market Size by Type (2021-2026) & (US$ Million) Table 108. Europe NGS Tumor Gene Analysis Software Market Size by Type (2027-2032) & (US$ Million) Table 109. Europe NGS Tumor Gene Analysis Software Market Size by Application (2021-2026) & (US$ Million) Table 110. Europe NGS Tumor Gene Analysis Software Market Size by Application (2027-2032) & (US$ Million) Table 111. Europe NGS Tumor Gene Analysis Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. Europe NGS Tumor Gene Analysis Software Market Size by Country (2021-2026) Table 113. Europe NGS Tumor Gene Analysis Software Market Size by Country (2027-2032) Table 114. China NGS Tumor Gene Analysis Software Market Size by Type (2021-2026) & (US$ Million) Table 115. China NGS Tumor Gene Analysis Software Market Size by Type (2027-2032) & (US$ Million) Table 116. China NGS Tumor Gene Analysis Software Market Size by Application (2021-2026) & (US$ Million) Table 117. China NGS Tumor Gene Analysis Software Market Size by Application (2027-2032) & (US$ Million) Table 118. Asia NGS Tumor Gene Analysis Software Market Size by Type (2021-2026) & (US$ Million) Table 119. Asia NGS Tumor Gene Analysis Software Market Size by Type (2027-2032) & (US$ Million) Table 120. Asia NGS Tumor Gene Analysis Software Market Size by Application (2021-2026) & (US$ Million) Table 121. Asia NGS Tumor Gene Analysis Software Market Size by Application (2027-2032) & (US$ Million) Table 122. Asia NGS Tumor Gene Analysis Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 123. Asia NGS Tumor Gene Analysis Software Market Size by Country (2021-2026) Table 124. Asia NGS Tumor Gene Analysis Software Market Size by Country (2027-2032) Table 125. South America, Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Type (2021-2026) & (US$ Million) Table 126. South America, Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Type (2027-2032) & (US$ Million) Table 127. South America, Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Application (2021-2026) & (US$ Million) Table 128. South America, Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Application (2027-2032) & (US$ Million) Table 129. South America, Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 130. South America, Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Country (2021-2026) Table 131. South America, Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Country (2027-2032) Table 132. Research Programs/Design for This Report Table 133. Authors List of This Report Table 134. Secondary Sources Table 135. Primary Sources List of Figures Figure 1. NGS Tumor Gene Analysis Software Product Image Figure 2. Global NGS Tumor Gene Analysis Software Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global NGS Tumor Gene Analysis Software Market Share by Type: 2025 VS 2032 Figure 4. Non-Small Cell Lung Cancer Image Figure 5. Human 6 Gene Mutations Image Figure 6. Human 12 Gene Mutations Image Figure 7. Other Image Figure 8. Global NGS Tumor Gene Analysis Software Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global NGS Tumor Gene Analysis Software Market Share by Application: 2025 VS 2032 Figure 10. Hospitals and Health Systems Image Figure 11. Research Institute Image Figure 12. Other Image Figure 13. Global NGS Tumor Gene Analysis Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global NGS Tumor Gene Analysis Software Market Size (2021-2032) & (US$ Million) Figure 15. Global NGS Tumor Gene Analysis Software Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global NGS Tumor Gene Analysis Software Market Share by Players in 2025 Figure 18. Global Top 5 and 10 NGS Tumor Gene Analysis Software Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global NGS Tumor Gene Analysis Software Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global NGS Tumor Gene Analysis Software Revenue Market Share by Type (2021-2032) Figure 22. Global NGS Tumor Gene Analysis Software Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global NGS Tumor Gene Analysis Software Revenue Market Share by Application (2021-2032) Figure 24. North America NGS Tumor Gene Analysis Software Market Size (2021-2032) & (US$ Million) Figure 25. North America NGS Tumor Gene Analysis Software Market Share by Type (2021-2032) Figure 26. North America NGS Tumor Gene Analysis Software Market Share by Application (2021-2032) Figure 27. North America NGS Tumor Gene Analysis Software Market Share by Country (2021-2032) Figure 28. United States NGS Tumor Gene Analysis Software Market Size (2021-2032) & (US$ Million) Figure 29. Canada NGS Tumor Gene Analysis Software Market Size (2021-2032) & (US$ Million) Figure 30. Mexico NGS Tumor Gene Analysis Software Market Size (2021-2032) & (US$ Million) Figure 31. Europe NGS Tumor Gene Analysis Software Market Size (2021-2032) & (US$ Million) Figure 32. Europe NGS Tumor Gene Analysis Software Market Share by Type (2021-2032) Figure 33. Europe NGS Tumor Gene Analysis Software Market Share by Application (2021-2032) Figure 34. Europe NGS Tumor Gene Analysis Software Market Share by Country (2021-2032) Figure 35. Germany NGS Tumor Gene Analysis Software Market Size (2021-2032) & (US$ Million) Figure 36. France NGS Tumor Gene Analysis Software Market Size (2021-2032) & (US$ Million) Figure 37. U.K. NGS Tumor Gene Analysis Software Market Size (2021-2032) & (US$ Million) Figure 38. Italy NGS Tumor Gene Analysis Software Market Size (2021-2032) & (US$ Million) Figure 39. Russia NGS Tumor Gene Analysis Software Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries NGS Tumor Gene Analysis Software Market Size (2021-2032) & (US$ Million) Figure 41. China NGS Tumor Gene Analysis Software Market Size (2021-2032) & (US$ Million) Figure 42. China NGS Tumor Gene Analysis Software Market Share by Type (2021-2032) Figure 43. China NGS Tumor Gene Analysis Software Market Share by Application (2021-2032) Figure 44. Asia NGS Tumor Gene Analysis Software Market Size (2021-2032) & (US$ Million) Figure 45. Asia NGS Tumor Gene Analysis Software Market Share by Type (2021-2032) Figure 46. Asia NGS Tumor Gene Analysis Software Market Share by Application (2021-2032) Figure 47. Asia NGS Tumor Gene Analysis Software Market Share by Country (2021-2032) Figure 48. Japan NGS Tumor Gene Analysis Software Market Size (2021-2032) & (US$ Million) Figure 49. South Korea NGS Tumor Gene Analysis Software Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan NGS Tumor Gene Analysis Software Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia NGS Tumor Gene Analysis Software Market Size (2021-2032) & (US$ Million) Figure 52. India NGS Tumor Gene Analysis Software Market Size (2021-2032) & (US$ Million) Figure 53. Australia NGS Tumor Gene Analysis Software Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa NGS Tumor Gene Analysis Software Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa NGS Tumor Gene Analysis Software Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa NGS Tumor Gene Analysis Software Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa NGS Tumor Gene Analysis Software Market Share by Country (2021-2032) Figure 58. Brazil NGS Tumor Gene Analysis Software Market Size (2021-2032) & (US$ Million) Figure 59. South Africa NGS Tumor Gene Analysis Software Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia NGS Tumor Gene Analysis Software Market Size (2021-2032) & (US$ Million) Figure 61. Turkey NGS Tumor Gene Analysis Software Market Size (2021-2032) & (US$ Million) Figure 62. Argentina NGS Tumor Gene Analysis Software Market Size (2021-2032) & (US$ Million) Figure 63. UAE NGS Tumor Gene Analysis Software Market Size (2021-2032) & (US$ Million) Figure 64. Egypt NGS Tumor Gene Analysis Software Market Size (2021-2032) & (US$ Million) Figure 65. Chile NGS Tumor Gene Analysis Software Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Non-Small Cell Lung Cancer
  • Human 6 Gene Mutations
  • Human 12 Gene Mutations
  • Other
Applications
  • Hospitals and Health Systems
  • Research Institute
  • Other
Companies covered
  • Roche
  • Illumina
  • Thermo Fisher Scientific
  • BGI Group
  • Novogene
  • Geneseeq
  • AmoyDx
  • Burning Rock Medicine
  • GTH.O
  • Golden Helix, Inc
  • Diatech Pharmacogenetics
  • ViennaLab Diagnostics GmbH
  • 3D Medicines

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global NGS Tumor Gene Analysis Software Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Non-Small Cell Lung Cancer
  5. 1.2.3 Human 6 Gene Mutations
  6. 1.2.4 Human 12 Gene Mutations
  7. 1.2.5 Other
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global NGS Tumor Gene Analysis Software Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Hospitals and Health Systems
  11. 1.3.3 Research Institute
  12. 1.3.4 Other
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global NGS Tumor Gene Analysis Software Growth Trends by Region
  15. 1.5.1 Global NGS Tumor Gene Analysis Software Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 NGS Tumor Gene Analysis Software Market Size by Region (2021-2026)
  17. 1.5.3 NGS Tumor Gene Analysis Software Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global NGS Tumor Gene Analysis Software Market Dynamics
  1. 2.1 NGS Tumor Gene Analysis Software Industry Trends
  2. 2.2 NGS Tumor Gene Analysis Software Industry Drivers
  3. 2.3 NGS Tumor Gene Analysis Software Industry Opportunities and Challenges
  4. 2.4 NGS Tumor Gene Analysis Software Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global NGS Tumor Gene Analysis Software Revenue by Company (2021-2026)
  2. 3.2 Global NGS Tumor Gene Analysis Software Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global NGS Tumor Gene Analysis Software Key Company Head office and Area Served
  4. 3.4 Global NGS Tumor Gene Analysis Software Company, Product Type & Application
  5. 3.5 Global NGS Tumor Gene Analysis Software Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global NGS Tumor Gene Analysis Software Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 NGS Tumor Gene Analysis Software Players Market Share by Revenue in 2025
  9. 3.6.3 2025 NGS Tumor Gene Analysis Software Tier 1, Tier 2, and Tier 3
4 NGS Tumor Gene Analysis Software Market by Type
  1. 4.1 Global NGS Tumor Gene Analysis Software Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global NGS Tumor Gene Analysis Software Market Size by Type (2021-2032)
  3. 4.3 Global NGS Tumor Gene Analysis Software Market Size Share by Type (2021-2032)
5 NGS Tumor Gene Analysis Software Market by Application
  1. 5.1 Global NGS Tumor Gene Analysis Software Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global NGS Tumor Gene Analysis Software Market Size by Application (2021-2032)
  3. 5.3 Global NGS Tumor Gene Analysis Software Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Roche
  2. 6.1.1 Roche Company Information
  3. 6.1.2 Roche Business Overview
  4. 6.1.3 Roche NGS Tumor Gene Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Roche NGS Tumor Gene Analysis Software Product Portfolio
  6. 6.1.5 Roche Recent Developments
  7. 6.2 Illumina
  8. 6.2.1 Illumina Company Information
  9. 6.2.2 Illumina Business Overview
  10. 6.2.3 Illumina NGS Tumor Gene Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Illumina NGS Tumor Gene Analysis Software Product Portfolio
  12. 6.2.5 Illumina Recent Developments
  13. 6.3 Thermo Fisher Scientific
  14. 6.3.1 Thermo Fisher Scientific Company Information
  15. 6.3.2 Thermo Fisher Scientific Business Overview
  16. 6.3.3 Thermo Fisher Scientific NGS Tumor Gene Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 Thermo Fisher Scientific NGS Tumor Gene Analysis Software Product Portfolio
  18. 6.3.5 Thermo Fisher Scientific Recent Developments
  19. 6.4 BGI Group
  20. 6.4.1 BGI Group Company Information
  21. 6.4.2 BGI Group Business Overview
  22. 6.4.3 BGI Group NGS Tumor Gene Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 BGI Group NGS Tumor Gene Analysis Software Product Portfolio
  24. 6.4.5 BGI Group Recent Developments
  25. 6.5 Novogene
  26. 6.5.1 Novogene Company Information
  27. 6.5.2 Novogene Business Overview
  28. 6.5.3 Novogene NGS Tumor Gene Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Novogene NGS Tumor Gene Analysis Software Product Portfolio
  30. 6.5.5 Novogene Recent Developments
  31. 6.6 Geneseeq
  32. 6.6.1 Geneseeq Company Information
  33. 6.6.2 Geneseeq Business Overview
  34. 6.6.3 Geneseeq NGS Tumor Gene Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Geneseeq NGS Tumor Gene Analysis Software Product Portfolio
  36. 6.6.5 Geneseeq Recent Developments
  37. 6.7 AmoyDx
  38. 6.7.1 AmoyDx Company Information
  39. 6.7.2 AmoyDx Business Overview
  40. 6.7.3 AmoyDx NGS Tumor Gene Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 AmoyDx NGS Tumor Gene Analysis Software Product Portfolio
  42. 6.7.5 AmoyDx Recent Developments
  43. 6.8 Burning Rock Medicine
  44. 6.8.1 Burning Rock Medicine Company Information
  45. 6.8.2 Burning Rock Medicine Business Overview
  46. 6.8.3 Burning Rock Medicine NGS Tumor Gene Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Burning Rock Medicine NGS Tumor Gene Analysis Software Product Portfolio
  48. 6.8.5 Burning Rock Medicine Recent Developments
  49. 6.9 GTH.O
  50. 6.9.1 GTH.O Company Information
  51. 6.9.2 GTH.O Business Overview
  52. 6.9.3 GTH.O NGS Tumor Gene Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 GTH.O NGS Tumor Gene Analysis Software Product Portfolio
  54. 6.9.5 GTH.O Recent Developments
  55. 6.10 Golden Helix, Inc
  56. 6.10.1 Golden Helix, Inc Company Information
  57. 6.10.2 Golden Helix, Inc Business Overview
  58. 6.10.3 Golden Helix, Inc NGS Tumor Gene Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Golden Helix, Inc NGS Tumor Gene Analysis Software Product Portfolio
  60. 6.10.5 Golden Helix, Inc Recent Developments
  61. 6.11 Diatech Pharmacogenetics
  62. 6.11.1 Diatech Pharmacogenetics Company Information
  63. 6.11.2 Diatech Pharmacogenetics Business Overview
  64. 6.11.3 Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  65. 6.11.4 Diatech Pharmacogenetics NGS Tumor Gene Analysis Software Product Portfolio
  66. 6.11.5 Diatech Pharmacogenetics Recent Developments
  67. 6.12 ViennaLab Diagnostics GmbH
  68. 6.12.1 ViennaLab Diagnostics GmbH Company Information
  69. 6.12.2 ViennaLab Diagnostics GmbH Business Overview
  70. 6.12.3 ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  71. 6.12.4 ViennaLab Diagnostics GmbH NGS Tumor Gene Analysis Software Product Portfolio
  72. 6.12.5 ViennaLab Diagnostics GmbH Recent Developments
  73. 6.13 3D Medicines
  74. 6.13.1 3D Medicines Company Information
  75. 6.13.2 3D Medicines Business Overview
  76. 6.13.3 3D Medicines NGS Tumor Gene Analysis Software Revenue and Gross Margin (US$ Million) & (2021-2026)
  77. 6.13.4 3D Medicines NGS Tumor Gene Analysis Software Product Portfolio
  78. 6.13.5 3D Medicines Recent Developments
7 North America
  1. 7.1 North America NGS Tumor Gene Analysis Software Market Size (2021-2032)
  2. 7.2 North America NGS Tumor Gene Analysis Software Market Size by Type
  3. 7.2.1 North America NGS Tumor Gene Analysis Software Market Size by Type (2021-2026)
  4. 7.2.2 North America NGS Tumor Gene Analysis Software Market Size by Type (2027-2032)
  5. 7.2.3 North America NGS Tumor Gene Analysis Software Market Share by Type (2021-2032)
  6. 7.3 North America NGS Tumor Gene Analysis Software Market Size by Application
  7. 7.3.1 North America NGS Tumor Gene Analysis Software Market Size by Application (2021-2026)
  8. 7.3.2 North America NGS Tumor Gene Analysis Software Market Size by Application (2027-2032)
  9. 7.3.3 North America NGS Tumor Gene Analysis Software Market Share by Application (2021-2032)
  10. 7.4 North America NGS Tumor Gene Analysis Software Market Size by Country
  11. 7.4.1 North America NGS Tumor Gene Analysis Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America NGS Tumor Gene Analysis Software Market Size by Country (2021-2026)
  13. 7.4.3 North America NGS Tumor Gene Analysis Software Market Size by Country (2027-2032)
  14. 7.4.4 North America NGS Tumor Gene Analysis Software Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe NGS Tumor Gene Analysis Software Market Size (2021-2032)
  2. 8.2 Europe NGS Tumor Gene Analysis Software Market Size by Type
  3. 8.2.1 Europe NGS Tumor Gene Analysis Software Market Size by Type (2021-2026)
  4. 8.2.2 Europe NGS Tumor Gene Analysis Software Market Size by Type (2027-2032)
  5. 8.2.3 Europe NGS Tumor Gene Analysis Software Market Share by Type (2021-2032)
  6. 8.3 Europe NGS Tumor Gene Analysis Software Market Size by Application
  7. 8.3.1 Europe NGS Tumor Gene Analysis Software Market Size by Application (2021-2026)
  8. 8.3.2 Europe NGS Tumor Gene Analysis Software Market Size by Application (2027-2032)
  9. 8.3.3 Europe NGS Tumor Gene Analysis Software Market Share by Application (2021-2032)
  10. 8.4 Europe NGS Tumor Gene Analysis Software Market Size by Country
  11. 8.4.1 Europe NGS Tumor Gene Analysis Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe NGS Tumor Gene Analysis Software Market Size by Country (2021-2026)
  13. 8.4.3 Europe NGS Tumor Gene Analysis Software Market Size by Country (2027-2032)
  14. 8.4.4 Europe NGS Tumor Gene Analysis Software Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China NGS Tumor Gene Analysis Software Market Size (2021-2032)
  2. 9.2 China NGS Tumor Gene Analysis Software Market Size by Type
  3. 9.2.1 China NGS Tumor Gene Analysis Software Market Size by Type (2021-2026)
  4. 9.2.2 China NGS Tumor Gene Analysis Software Market Size by Type (2027-2032)
  5. 9.2.3 China NGS Tumor Gene Analysis Software Market Share by Type (2021-2032)
  6. 9.3 China NGS Tumor Gene Analysis Software Market Size by Application
  7. 9.3.1 China NGS Tumor Gene Analysis Software Market Size by Application (2021-2026)
  8. 9.3.2 China NGS Tumor Gene Analysis Software Market Size by Application (2027-2032)
  9. 9.3.3 China NGS Tumor Gene Analysis Software Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia NGS Tumor Gene Analysis Software Market Size (2021-2032)
  2. 10.2 Asia NGS Tumor Gene Analysis Software Market Size by Type
  3. 10.2.1 Asia NGS Tumor Gene Analysis Software Market Size by Type (2021-2026)
  4. 10.2.2 Asia NGS Tumor Gene Analysis Software Market Size by Type (2027-2032)
  5. 10.2.3 Asia NGS Tumor Gene Analysis Software Market Share by Type (2021-2032)
  6. 10.3 Asia NGS Tumor Gene Analysis Software Market Size by Application
  7. 10.3.1 Asia NGS Tumor Gene Analysis Software Market Size by Application (2021-2026)
  8. 10.3.2 Asia NGS Tumor Gene Analysis Software Market Size by Application (2027-2032)
  9. 10.3.3 Asia NGS Tumor Gene Analysis Software Market Share by Application (2021-2032)
  10. 10.4 Asia NGS Tumor Gene Analysis Software Market Size by Country
  11. 10.4.1 Asia NGS Tumor Gene Analysis Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia NGS Tumor Gene Analysis Software Market Size by Country (2021-2026)
  13. 10.4.3 Asia NGS Tumor Gene Analysis Software Market Size by Country (2027-2032)
  14. 10.4.4 Asia NGS Tumor Gene Analysis Software Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa NGS Tumor Gene Analysis Software Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Type
  3. 11.2.1 South America, Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa NGS Tumor Gene Analysis Software Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Application
  7. 11.3.1 South America, Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa NGS Tumor Gene Analysis Software Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Country
  11. 11.4.1 South America, Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa NGS Tumor Gene Analysis Software Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa NGS Tumor Gene Analysis Software Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst